Eye2Gene
PrivateLast Round
Seed
Nov 19, 2025
Total Funding Raised
$2.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eye2Gene is a healthcare technology company that has developed a precision ophthalmology platform to improve the diagnosis of genetic eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Computer Vision, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eye2Gene Comparables
Compare Eye2Gene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| deepeye Medical | 74% | |
| Altris AI | 72% | |
| Topcon Corporation | 69% | |
Eye2Gene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 19, 2025 | ||||
| Grant | May 8, 2025 | ||||
| Grant | Jun 16, 2021 |
Eye2Gene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Medical Research Foundation | Grant |
| DHSC | Grant |
| NHS AI Lab | Grant |
| NHS Accelerated Access Collaborative | Grant |
| National Institute for Health and Care Research | Grant |
| Twin Path Ventures | Seed |
| Moorfields Eye Charity | Grant, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
$921K raised with Twin Path Ventures participating.
- May 8, 2025
Received grant funding from Medical Research Foundation, Moorfields Eye Charity, and Sight Research UK.
Eye2Gene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eye2Gene's valuation, stock price, and market status.